000 01386 a2200373 4500
005 20250513155757.0
264 0 _c19990106
008 199901s 0 0 eng d
022 _a0002-9165
024 7 _a10.1093/ajcn/68.6.1496S
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKing, R A
245 0 0 _aDaidzein conjugates are more bioavailable than genistein conjugates in rats.
_h[electronic resource]
260 _bThe American journal of clinical nutrition
_c12 1998
300 _a1496S-1499S p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article
650 0 4 _aAdministration, Oral
650 0 4 _aAnimals
650 0 4 _aBiological Availability
650 0 4 _aChromans
_xurine
650 0 4 _aChromatography, High Pressure Liquid
650 0 4 _aEnzyme Inhibitors
_xadministration & dosage
650 0 4 _aEquol
650 0 4 _aEstrogens, Non-Steroidal
_xpharmacokinetics
650 0 4 _aGenistein
_xadministration & dosage
650 0 4 _aIsoflavones
_xadministration & dosage
650 0 4 _aMale
650 0 4 _aMonoamine Oxidase Inhibitors
_xurine
650 0 4 _aRats
650 0 4 _aRats, Wistar
650 0 4 _aSoybean Proteins
_xadministration & dosage
773 0 _tThe American journal of clinical nutrition
_gvol. 68
_gno. 6 Suppl
_gp. 1496S-1499S
856 4 0 _uhttps://doi.org/10.1093/ajcn/68.6.1496S
_zAvailable from publisher's website
999 _c9811634
_d9811634